OANNESBIOTECH

The Library

Insights

A running archive of biotech and molecular biology news, explained clearly — new mechanisms, new therapies, and the research behind them.

Unraveling the Link Between Survival Genes and Neurotoxicity in Alzheimer’s Disease and Aging

January 22, 2024

Unraveling the Link Between Survival Genes and Neurotoxicity in Alzheimer’s Disease and Aging

In a groundbreaking study recently published in Nature Communications, scientists from Northwestern University and various research institutions have shed light on a previously…

Aging (Developmental biology)Alzheimer disease
Read Article
Revolutionizing RNA Research: Unveiling the Power of KARR-seq

January 19, 2024

Revolutionizing RNA Research: Unveiling the Power of KARR-seq

In the ever-evolving landscape of molecular biology, a novel method named KARR-seq (Kethoxal-Assisted Rapid RNA sequencing) has emerged as a game-changer, propelling our…

Read Article
Unveiling a Potential Breakthrough: Human Type 2 Innate Lymphoid Cells Target Cancer in Preclinical Study

January 15, 2024

Unveiling a Potential Breakthrough: Human Type 2 Innate Lymphoid Cells Target Cancer in Preclinical Study

In a remarkable stride towards advancing cancer therapeutics, researchers at City of Hope have unveiled groundbreaking findings in their preclinical study titled “ Therapeutic…

Read Article
Boehringer Ingelheim’s Expands and Upgrades its Production Site in Koropi, Greece

January 12, 2024

Boehringer Ingelheim’s Expands and Upgrades its Production Site in Koropi, Greece

In a strategic move to fortify its global presence and enhance pharmaceutical production capabilities, Boehringer Ingelheim, the pharmaceutical giant, has announced the further…

Read Article
GSK and Tempus Forge Ahead: A Pioneering Collaboration in Precision Medicine to Propel R&D

January 8, 2024

GSK and Tempus Forge Ahead: A Pioneering Collaboration in Precision Medicine to Propel R&D

In a significant stride towards advancing precision medicine, GlaxoSmithKline (GSK) has announced a three-year collaboration agreement with Tempus, a leader in data-driven…

AI
Read Article
Gradalis’ GRAD1405 bi-shRNAi Breakthrough: A Triumphant Stride Against Drug-Resistant Cancers

January 5, 2024

Gradalis’ GRAD1405 bi-shRNAi Breakthrough: A Triumphant Stride Against Drug-Resistant Cancers

In a significant leap forward in the ongoing battle against drug-resistant cancers, Gradalis, a forefront player in personalized cancer immunotherapy, has unveiled promising…

Read Article
Breaking Ground: AI Unleashes a New Era in Antibiotic Discovery

January 3, 2024

Breaking Ground: AI Unleashes a New Era in Antibiotic Discovery

In a groundbreaking development, a team of scientists have discovered a new class of antibiotics using artificial intelligence, marking the first such breakthrough in over six…

Antibiotic ResistanceAntibioticsArtificial Intelligence
Read Article
Pioneering the Future: European Medicines Agency and Heads of Medicines Agencies Unveil AI Workplan

January 2, 2024

Pioneering the Future: European Medicines Agency and Heads of Medicines Agencies Unveil AI Workplan

A Strategic Roadmap to Harness the Power of Artificial Intelligence in Medicines Regulation In a bold leap towards innovation, the European Medicines Agency (EMA) and the Heads of…

Read Article
Pfizer Makes Waves in Biopharmaceuticals with $43 Billion Seagen Acquisition

December 27, 2023

Pfizer Makes Waves in Biopharmaceuticals with $43 Billion Seagen Acquisition

In a strategic move that is set to reshape the landscape of the biopharmaceutical industry, Pfizer has announced its monumental $43 billion acquisition of Seagen. This landmark…

Read Article
AstraZeneca and Absci Join Forces in a $247 Million Deal to Combat Cancer with Innovative Antibody Design

December 22, 2023

AstraZeneca and Absci Join Forces in a $247 Million Deal to Combat Cancer with Innovative Antibody Design

In a groundbreaking move to advance cancer therapeutics, AstraZeneca, a global pharmaceutical giant, has recently entered into a strategic collaboration with Absci, a leading…

Read Article
Major Milestone: FDA Grants Approval to Vertex and CRISPR Therapeutics for CASGEVY™ in the Treatment of Sickle Cell Disease

December 12, 2023

Major Milestone: FDA Grants Approval to Vertex and CRISPR Therapeutics for CASGEVY™ in the Treatment of Sickle Cell Disease

Groundbreaking Gene-Editing Therapy Receives Green Light, Signaling a New Era in Sickle Cell Treatment Date: 12 December 2023 Introduction: In a landmark decision, the U.S. Food…

Read Article
Revolutionizing Treatment: UK Grants Authorization to Vertex Pharmaceuticals and CRISPR Therapeutics for Groundbreaking CRISPR/Cas9 Gene-Edited Therapy

December 11, 2023

Revolutionizing Treatment: UK Grants Authorization to Vertex Pharmaceuticals and CRISPR Therapeutics for Groundbreaking CRISPR/Cas9 Gene-Edited Therapy

MHRA Approves CASGEVY™ for Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia, Marking a Milestone in Precision Medicine Date: 7 December 2023 Introduction: In a…

Read Article
← NewerPage 10 / 10